Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF

被引：1
作者：
Jimenez-Vicente, Carlos [1 ,2 ,3 ]
Martinez-Roca, Alexandra [1 ,2 ]
Pomares, Helena [2 ,4 ]
Castano-Diez, Sandra [1 ,2 ]
Guijarro, Francesca [2 ,5 ]
Lopez-Guerra, Monica [2 ,5 ,6 ]
Bataller, Alex [1 ,2 ,7 ]
Esteban, Daniel [1 ,2 ]
Cortes-Bullich, Albert [1 ,2 ]
Perez-Valencia, Amanda Isabel [1 ,2 ]
Guardia-Torrelles, Ares [1 ]
Zugasti, Ines [1 ]
Rovira, Montserrat [1 ,2 ,3 ]
Fernandez-Aviles, Francesc [1 ,2 ]
Colomer, Dolors [2 ,5 ]
Arnan, Montserrat [2 ,4 ]
Diaz-Beya, Marina [1 ,2 ,7 ]
Esteve, Jordi [1 ,2 ,3 ,7 ,8 ]
机构：
[1] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain
[2] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[3] Univ Barcelona, Barcelona, Spain
[4] Univ Barcelona, Hosp Duran i Reynals, Inst Catala Oncol, Hematol Dept, Barcelona, Spain
[5] Hosp Clin Barcelona, Pathol Dept, Hemopathol Unit, Barcelona, Spain
[6] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[7] Josep Carreras Leukemia Res Inst, Barcelona, Spain
[8] Hosp Clin Barcelona, Dept Hematol, Villarroel 170, Barcelona 08036, Spain
来源：
LEUKEMIA RESEARCH | 2023年 / 135卷
关键词：
AML; Preemptive treatment; MRD; REMISSION; AZACITIDINE;
D O I：
10.1016/j.leukres.2023.107403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 15 条
  • [1] Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
    Buckley, Sarah A.
    Wood, Brent L.
    Othus, Megan
    Hourigan, Christopher S.
    Ustun, Celalettin
    Linden, Michael A.
    DeFor, Todd E.
    Malagola, Michele
    Anthias, Chloe
    Valkova, Veronika
    Kanakry, Christopher G.
    Gruhn, Bernd
    Buccisano, Francesco
    Devine, Beth
    Walter, Roland B.
    [J]. HAEMATOLOGICA, 2017, 102 (05) : 865 - 873
  • [2] Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia
    Chua, Chong Chyn
    Hammond, Danielle
    Kent, Andrew
    Tiong, Ing Soo
    Konopleva, Marina Y.
    Pollyea, Daniel A.
    DiNardo, Courtney D.
    Wei, Andrew H.
    [J]. BLOOD ADVANCES, 2022, 6 (13) : 3879 - 3883
  • [3] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    DiNardo, C. D.
    Jonas, B. A.
    Pullarkat, V.
    Thirman, M. J.
    Garcia, J. S.
    Wei, A. H.
    Konopleva, M.
    Doehner, H.
    Letai, A.
    Fenaux, P.
    Koller, E.
    Havelange, V.
    Leber, B.
    Esteve, J.
    Wang, J.
    Pejsa, V.
    Hajek, R.
    Porkka, K.
    Illes, A.
    Lavie, D.
    Lemoli, R. M.
    Yamamoto, K.
    Yoon, S. -S.
    Jang, J. -H.
    Yeh, S. -P.
    Turgut, M.
    Hong, W. -J.
    Zhou, Y.
    Potluri, J.
    Pratz, K. W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
  • [4] Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
    DiNardo, Courtney D.
    Lachowiez, Curtis A.
    Takahashi, Koichi
    Loghavi, Sanam
    Kadia, Tapan
    Daver, Naval
    Xiao, Lianchun
    Adeoti, Maria
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Borthakur, Gautam
    Issa, Ghayas
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Bravo, Guillermo Montalban
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : 1035 - 1043
  • [5] Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
    Doehner, Hartmut
    Wei, Andrew H.
    Roboz, Gail J.
    Montesinos, Pau
    Thol, Felicitas R.
    Ravandi, Farhad
    Dombret, Herve
    Porkka, Kimmo
    Sandhu, Irwindeep
    Skikne, Barry
    See, Wendy L.
    Ugidos, Manuel
    Risueno, Alberto
    Chan, Esther T.
    Thakurta, Anjan
    Beach, C. L.
    de Menezes, Daniel Lopes
    [J]. BLOOD, 2022, 140 (15) : 1674 - 1685
  • [6] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
    Doehner, Hartmut
    Estey, Elihu
    Grimwade, David
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Larson, Richard A.
    Levine, Ross L.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel
    Sierra, Jorge
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wei, Andrew H.
    Lowenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2017, 129 (04) : 424 - 447
  • [7] Dohner H., 2022, 64 ASH ANN M EXP INT
  • [8] 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
    Heuser, Michael
    Freeman, Sylvie D.
    Ossenkoppele, Gert J.
    Buccisano, Francesco
    Hourigan, Christopher S.
    Ngai, Lok Lam
    Tettero, Jesse M.
    Bachas, Costa
    Baer, Constance
    Bene, Marie-Christine
    Bucklein, Veit
    Czyz, Anna
    Denys, Barbara
    Dillon, Richard
    Feuring-Buske, Michaela
    Guzman, Monica L.
    Haferlach, Torsten
    Han, Lina
    Herzig, Julia K.
    Jorgensen, Jeffrey L.
    Kern, Wolfgang
    Konopleva, Marina Y.
    Lacombe, Francis
    Libura, Marta
    Majchrzak, Agata
    Maurillo, Luca
    Ofran, Yishai
    Philippe, Jan
    Plesa, Adriana
    Preudhomme, Claude
    Ravandi, Farhad
    Roumier, Christophe
    Subklewe, Marion
    Thol, Felicitas
    van de Loosdrecht, Arjan A.
    van der Reijden, Bert A.
    Venditti, Adriano
    Wierzbowska, Agnieszka
    Valk, Peter J. M.
    Wood, Brent L.
    Walter, Roland B.
    Thiede, Christian
    Dohner, Konstanze
    Roboz, Gail J.
    Cloos, Jacqueline
    [J]. BLOOD, 2021, 138 (26) : 2753 - 2767
  • [9] Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens
    Lachowiez, Curtis A.
    Loghavi, Sanam
    Kadia, Tapan M.
    Daver, Naval
    Borthakur, Gautam
    Pemmaraju, Naveen
    Naqvi, Kiran
    Alvarado, Yesid
    Yilmaz, Musa
    Short, Nicholas
    Ohanian, Maro
    Pierce, Sherry R.
    Patel, Keyur P.
    Qiao, Wei
    Ning, Jing
    Sasaki, Koji
    Takahashi, Koichi
    Jabbour, Elias
    Andreeff, Michael
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina
    DiNardo, Courtney D.
    [J]. BLOOD ADVANCES, 2020, 4 (07) : 1311 - 1320
  • [10] Impact of Venetoclax and Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia and IDH1/2 Mutations
    Pollyea, Daniel A.
    DiNardo, Courtney D.
    Arellano, Martha L.
    Pigneux, Arnaud
    Fiedler, Walter
    Konopleva, Marina
    Rizzieri, David A.
    Smith, B. Douglas
    Shinagawa, Atsushi
    Lemoli, Roberto M.
    Dail, Monique
    Duan, Yinghui
    Chyla, Brenda
    Potluri, Jalaja
    Miller, Catherine L.
    Kantarjian, Hagop M.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2753 - 2761
12